Zhuge, L., Huang, B., Xie, J., Gao, Z., Zheng, D., Zheng, S., . . . Zhang, J. (2020). Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma. Cancer Manag Res.
Chicago-stil citatZhuge, Lingdun, Binhao Huang, Juntao Xie, Zhendong Gao, Difan Zheng, Shanbo Zheng, Jiaqing Xiang, och Jie Zhang. "Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma." Cancer Manag Res 2020.
MLA-referensZhuge, Lingdun, et al. "Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma." Cancer Manag Res 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.